CF
MEDP icon

Cantor Fitzgerald’s Medpace MEDP Stock Holding History

Cantor Fitzgerald’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-71,725
Closed -$17.4M – 432
2023
Q3 		$17.4M Buy
71,725
+69,670
+3,390% +$17.8M 0.46% 73
2023
Q2 		$494K Hold
2,055
– – 0.01% 370
2023
Q1 		$386K Sell
2,055
-68
-3% -$14.1K 0.01% 458
2022
Q4 		$451K Buy
2,123
+15
+0.7% +$3K 0.01% 476
2022
Q3 		$331K Sell
2,108
-15
-0.7% -$2.39K 0.01% 551
2022
Q2 		$318K Buy
+2,123
New +$307K 0.01% 598

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Cantor Fitzgerald's MEDP Position: Q4 2023 in Review

Cantor Fitzgerald sold out of Medpace (MEDP) in Q4 2023, closing a stake of 71,725 shares — an estimated $17.4M sold.

Cantor Fitzgerald first reported a position in MEDP in Q2 2022 and held it in 6 quarters. The position peaked at $17.4M in Q3 2023. 544 funds tracked by Wall St. Rank hold MEDP as of Q4 2023.

  • Cantor Fitzgerald reported no remaining Medpace position as of Q4 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 71,725 Medpace shares in Q4 2023, an estimated $17.4M.
  • Cantor Fitzgerald first reported a position in Medpace in Q2 2022 and held it in 6 quarters.
  • Cantor Fitzgerald's Medpace position peaked at $17.4M in Q3 2023.
  • 544 funds tracked by Wall St. Rank held Medpace as of Q4 2023.

Based on Cantor Fitzgerald's 13F filing for Q4 2023, filed 14 Feb 2024.